Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?

Table 2

Laboratory results according to the presence of high liver stiffness measurement (LSM > 7 kPa).

	All patients	LSM ≤ 7 kPa	LSM > 7 kPa
	()	()	()
AST (U/L)^†	28.2 ± 13.6	27.1 ± 10.6	37.6 ± 26.7	0.002
ALT (U/L)^†	41.2 ± 23.0	39.3 ± 19.6	56.4 ± 39.3	0.003
Fasting glucose (mg/dL)^†	108.4 ± 38.3	103.8 ± 29.7	146.0 ± 69.8	<0.0001
Triglyceride (mg/dL)^†	126.1 ± 67.8	125.5 ± 68.7	131.3 ± 61.5	0.712
TC (mg/dL)^†	202.8 ± 42.9	203.6 ± 42.0	194.0 ± 49.9	0.431
LDL-C (mg/dL)^†	126.1 ± 35.3	126.4 ± 34.3	123.4 ± 44.0	0.781
HDL-C (mg/dL)^†	50.5 ± 13.2	51.1 ± 13.1	45.4 ± 13.0	0.095
HOMA-IR^†	3.8 ± 6.1	3.1 ± 3.4	9.9 ± 14.8	<0.0001
LSM (kPa)^†	5.3 ± 2.9	4.5 ± 1.2	11.5 ± 4.7	<0.0001
Fatty liver by US^‡	105 (63.6%)	89 (60.5%)	16 (88.9%)	0.019

LSM: liver stiffness measurement; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostatic model assessment insulin resistance; US: ultrasonography; ^†mean ± SD; ^‡ (%).